ISRG et al - Robotic assisted surgeries commentary link. It will take a year of sales data to see if the space expands and/or if any market share changes occur. I expect ISRG domination to continue where they dominate now so no "shakeup" for now. I hold TRXC because of utilization data and reviews from busy EU centers using currently cleared instruments. I would like to hear from American surgeons but that will take time and a few hundred cases as in EU before we get reports back.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.